Literature DB >> 24434643

Ischemic preconditioning protects cardiomyocyte mitochondria through mechanisms independent of cytosol.

Marisol Ruiz-Meana1, Estefanía Núñez2, Elisabet Miro-Casas1, Pablo Martínez-Acedo2, Ignasi Barba1, Antonio Rodriguez-Sinovas1, Javier Inserte1, Celia Fernandez-Sanz1, Victor Hernando1, Jesús Vázquez3, David Garcia-Dorado4.   

Abstract

Mitochondria play a central role in the protection conferred by ischemic preconditioning (IP) by not fully elucidated mechanisms. We investigated whether IP protects mitochondria against ischemia-reperfusion (IR) injury through mechanisms independent of cytosolic signaling. In isolated rat hearts, sublethal IR increased superoxide production and reduced complex-I- and II-mediated respiration in subsarcolemmal (SS), but not interfibrillar (IF) mitochondria. This effect of IR on mitochondrial respiration was significantly attenuated by IP. Similar results were obtained in isolated cardiac mitochondria subjected to in vitro IR. The reduction in SS mitochondrial respiration in the heart and in vitro model was paralleled by an increase in oxidized cysteine residues, which was also prevented by IP. IP was also protective in mitochondria submitted to lethal IR. The protective effect of IP against respiratory failure was unaffected by inhibition of mitochondrial KATP channels or mitochondrial permeability transition. However, IP protection was lost in mitochondria from genetically-modified animals in which connexin-43, a protein present in SS but not IF mitochondria, was replaced by connexin-32. Our results demonstrate the existence of a protective mitochondrial mechanism or "mitochondrial preconditioning" independent of cytosol that confers protection against IR-induced respiratory failure and oxidative damage, and requires connexin-43.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardioprotection; Heart; Ischemia; Mitochondria; Reperfusion

Mesh:

Substances:

Year:  2014        PMID: 24434643     DOI: 10.1016/j.yjmcc.2014.01.001

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  21 in total

Review 1.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

2.  Effects of ischemic preconditioning on the systemic and renal hemodynamic changes in renal ischemia reperfusion injury.

Authors:  Yu-Zheng Ge; Ran Wu; Hui Xin; Hao Liu; Tian-Ze Lu; You-Cai Zhao; Jiang-Wei Shen; Zhi-Kai Hu; Peng Yu; Liu-Hua Zhou; Lu-Wei Xu; Zheng Xu; Jian-Ping Wu; Wen-Cheng Li; Jia-Geng Zhu; Rui-Peng Jia
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 3.  Dysregulation of Mfn2 and Drp-1 proteins in heart failure.

Authors:  Srikanth Givvimani; Sathnur Pushpakumar; Sudhakar Veeranki; Suresh C Tyagi
Journal:  Can J Physiol Pharmacol       Date:  2014-05-09       Impact factor: 2.273

Review 4.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

Review 5.  Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart.

Authors:  John P Headrick; Louise E See Hoe; Eugene F Du Toit; Jason N Peart
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 6.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

7.  Ischaemic preconditioning preferentially increases protein S-nitrosylation in subsarcolemmal mitochondria.

Authors:  Junhui Sun; Tiffany Nguyen; Angel M Aponte; Sara Menazza; Mark J Kohr; David M Roth; Hemal H Patel; Elizabeth Murphy; Charles Steenbergen
Journal:  Cardiovasc Res       Date:  2015-02-18       Impact factor: 10.787

8.  Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.

Authors:  Sandrine Morel; Christina Christoffersen; Lene N Axelsen; Fabrizio Montecucco; Viviane Rochemont; Miguel A Frias; Francois Mach; Richard W James; Christian C Naus; Marc Chanson; Paul D Lampe; Morten S Nielsen; Lars B Nielsen; Brenda R Kwak
Journal:  Cardiovasc Res       Date:  2016-01-13       Impact factor: 10.787

Review 9.  Connexin Gap Junctions and Hemichannels Link Oxidative Stress to Skeletal Physiology and Pathology.

Authors:  Rui Hua; Jingruo Zhang; Manuel A Riquelme; Jean X Jiang
Journal:  Curr Osteoporos Rep       Date:  2021-01-06       Impact factor: 5.096

10.  Increased protein S-nitrosylation in mitochondria: a key mechanism of exercise-induced cardioprotection.

Authors:  Doria Boulghobra; Mathilde Dubois; Béatrice Alpha-Bazin; Florence Coste; Maxime Olmos; Sandrine Gayrard; Isabelle Bornard; Gregory Meyer; Jean-Charles Gaillard; Jean Armengaud; Cyril Reboul
Journal:  Basic Res Cardiol       Date:  2021-12-23       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.